Radiopharmaceuticals Market Rising at 9.30% CAGR Due to Expanding Cancer Diseases

Owing to the upsurge in the prevalence of cardiovascular chronic diseases and cancer radiopharmaceuticals market is expected to bring in USD 11.85 billion by 2026.  The increasing rate of chronic diseases and its diagnosis and treatment in the early stages of cancer is driving the market growth of the radiopharmaceuticals market across the world.

Due to this progression the market is expected to propel by 9.30% of annual growth rate in the forecasted period of 2019 to 2026. The accelerating initiative adopted by government and healthcare sector for providing sustainable radiopharmaceuticals services will propel the market growth in the expected time frame.

Radiopharmaceuticals Market Scenario

According to Data Bridge Market Research the market for radiopharmaceuticals is booming with the rising expenditure in the healthcare solutions. The demand of technological elevations and progress which authorizes the practice of monoclonal antibodies and radio-labeled peptides for the operation and diagnosis of carcinogenic cysts and augmenting inclination towards PET and SPECT scan and gaining bent towards virus targeted tumor therapeutics is expected to accelerate the growth of radiopharmaceuticals market in the anticipated time phase.

The rising demand of healthcare sector integration with the boosting expenditure on the research and development of radiopharmaceuticals and rising familiarity of the same amidst emerging nations will increase the share stocks and market value of radiopharmaceuticals market. Few of the factors will acts as restraint to curb down the market growth such as rigorous administrative guidelines and tremendous expense of tools using radioisotopes will hamper the market growth. Also the undersized life expectancy of radiopharmaceutical will hinder the growth of radiopharmaceuticals market.

Now the question is which are the other regions that radiopharmaceuticals market is targeting? Data Bridge Market Research has forecasted a large growth in Asia-Pacific (APAC) region due to the increment in health tourism, the increasing rate of healthcare sector will also create a deep crater for market growth of radiopharmaceuticals market. North America is expected to dominate the global share and market due to advanced healthcare cost system and germinating cancer and cardiovascular chronic diseases.

For More Analysis on the radiopharmaceuticals market request for a briefing with our analysts

Radiopharmaceuticals Market Development and Acquisitions in 2019

  • In December 2019, a significant development was accounted for the expansion of radiopharmaceuticals exchange between Curium and Finnish. Curium has accomplished the purchase of Finnish Radiopharmaceuticals Corporation of MAP medical technologies Oy. This merger of MAP Medical will moreover extend Curium’s trail in Europe, rendering straight entrance to Nordic and Baltic realms for its comprehensive holdings of diagnostic resolutions.

Radiopharmaceuticals Market Scope

The Radiopharmaceuticals Market is segmented on the basis of countries into U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

  • All country based analysis of the radiopharmaceuticals market is further analyzed based on maximum granularity into further segmentation. On the basis type, radiopharmaceuticals market is segmented into diagnostic nuclear medicine, therapeutic nuclear medicine. On the basis of application, the radiopharmaceuticals market is fragmented into diagnostic, and therapeutic. On the procedural volume, market is bifurcated into diagnostic procedures, therapeutic procedures. On the basis of source, the market is segmented into nuclear reactors, cyclotrons. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutes, others.
  • Radiopharmaceuticals are an accumulation of pharma medicine which has radiation intact in them. It can be adopted as a remedial agent. Radiopharmaceuticals are unusual therapeutic formulations comprising radioactive isotopes which are practiced in significant clinical section for analysis or treatment.

To know more about the study

Key Pointers Covered in the Radiopharmaceuticals Market Industry Trends and Forecast to 2026

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the report

  • Cardinal Health
  • Mallinckrodt
  • General Electric Company
  • Lantheus Medical Imaging, Inc
  • Bayer AG
  •  Bracco Imaging S.p.A
  • Nordion (Canada) Inc
  • Advanced Accelerator Applications
  • Surgery Theater
  • Positron Corporation
  • NTP
  • IsoPET
  • Eli Lilly and Company
  • Jubilant Pharma LLC
  •  Actinium Pharmaceuticals Inc
  •  Immunomedics, Inc
  •  Areva Pharma
  • Merck & Co Inc
  •  Navidea Biopharmaceuticals Inc
  • Eckert & Ziegler
  •  Siemens Healthcare Private Limited
  •  Novartis AG
  •  Curium

Above are the key players covered in the report to know about more and exhaustive list of radiopharmaceuticals market companies’ contact us

Research Methodology of Global Radiopharmaceuticals Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@